Pharmaceutical Executive
"Tired of your old birth-control routine?" the spot asks. "Maybe it's time to break free from the pack with NuvaRing."
BREAK FREE FROM THE PACK
TBWA/WorldHealth
BRAND NuvaRing CLIENT Schering-Plough CLOCKWISE FROM FRONT LEFT: Leticia Freytes, account executive; Matthew Damron, group account director; Leo Zanis, associate creative director; Gary Scheiner, executive creative director; Cristin Ryan, account director; Anne Devereux, chairman and CEO
"Tired of your old birth-control routine?" the spot asks. "Maybe it's time to break free from the pack with NuvaRing."
Schering-Plough's DTC ad "Break Free from the Pack" presented a platform built on disruption—not one of pharma's favorite themes. "Disruption is a scary word, but it doesn't necessarily have to be scary or mean crazy," says Gary Scheiner, executive creative director and main writer, TBWA/WorldHealth. "Disruption is merely a way of dismantling the status quo and replacing it with something bold and new."
Working together, client and agency decided on a big, disruptive idea. They were inspired by the work of 1930s film director Busby Berkeley, who is best known for elaborate synchronized dance routines on stage and in water.
TBWA/WorldHealth worked with world-renowned fashion photographer Matthew Rolston to add beautiful staging and tell the NuvaRing story. Identically clad swimmers communicated the monotonous routine of taking oral contraceptives by chanting the original song "Monday, Tuesday, Wednesday..." When the heroine realizes she can break from the routine, she steps out of the pool, tears the day off her chest, and becomes the modern woman who chooses NuvaRing.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.